Bionic vision system developer Pixium Vision has received approval from the Medicines & Healthcare products Regulatory Agency (MHRA) in the UK to begin a clinical trial for its IRIS® II bionic vision system.
The clinical trial will reportedly be for patients who have lost their sight from retinitis pigmentosa (RP), and will evaluate a system that includes a mini bio-inspired camera and a 150 electrode epi-retinal implant with an explantable design.
Click here to read the full press release.